Court of Justice 22 April 2010, C-350/08 (European Commission v Republic of Lithuania.)
Also known as
European Union · · · Cited by 3 · 22-04-2010
Opinion of the Advocate-General Opinion of the Advocate-General I – Introduction 1. Grasalva is a medicinal product derived from bio-technology that is used in chemotherapy treatments. (2) It is similar to another medicinal product, called ‘Neupogen’, already authorised in the European Union. (3) 2.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (3 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit